253 related articles for article (PubMed ID: 34544437)
1. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.
Luo F; Zeng KM; Cao JX; Zhou T; Lin SX; Ma WJ; Yang YP; Zhang ZH; Lu FT; Huang Y; Zhao HY; Zhang L
Lipids Health Dis; 2021 Sep; 20(1):109. PubMed ID: 34544437
[TBL] [Abstract][Full Text] [Related]
2. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.
Wang Y; Wang ZQ; Wang FH; Lei XF; Yan SM; Wang DS; Zhang F; Xu RH; Wang LY; Li YH
Oncotarget; 2016 Aug; 7(35):57290-57300. PubMed ID: 27344180
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
[TBL] [Abstract][Full Text] [Related]
6. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
Tang M; Song C; Zhang Y; Xu X; Wang C; Zhang Z; Chen T
Lipids Health Dis; 2021 Nov; 20(1):165. PubMed ID: 34801029
[TBL] [Abstract][Full Text] [Related]
7. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
[TBL] [Abstract][Full Text] [Related]
8. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of preoperative serum triglyceride, high-density lipoprotein, and low-density lipoprotein levels in lung squamous cell carcinoma.
Li Z; Xu J; Feng W; Ma Z; Wu Y; Zhu T; Xu P; Dong L; Ding J; Zhou J; Yu G
Sci Rep; 2022 Oct; 12(1):16828. PubMed ID: 36207435
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.
Soran H; France MW; Kwok S; Dissanayake S; Charlton-Menys V; Younis NN; Durrington PN
Ann Clin Biochem; 2011 Nov; 48(Pt 6):566-71. PubMed ID: 22006975
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.
Ma C; Wang X; Guo J; Liu P
Lipids Health Dis; 2021 Oct; 20(1):69. PubMed ID: 34598703
[TBL] [Abstract][Full Text] [Related]
12. Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer.
Lin Q; Liu W; Xu S; Sun L
Arch Gynecol Obstet; 2022 Mar; 305(3):683-691. PubMed ID: 34453586
[TBL] [Abstract][Full Text] [Related]
13. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
[No Abstract] [Full Text] [Related]
14. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
Wen M; Wang L; Wang X; Yang S; Sun Y; Xia J; Zhang Y; Zhang Z; Huang L; Jiang T
Oncol Res Treat; 2020; 43(12):686-693. PubMed ID: 33197924
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
Yan S; Shun-Chang J; Li C; Jie L; Ya-Li L; Ling-Xiong W
BMC Cancer; 2010 Nov; 10():621. PubMed ID: 21067592
[TBL] [Abstract][Full Text] [Related]
16. High BMI and low HDL-C predict the chemotherapy-related hepatic dysfunction in Chinese advanced NSCLC patients.
Lv Y; Ding XS; Li Y; An X; Miao LY
Cancer Biomark; 2016; 16(1):89-97. PubMed ID: 26835709
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
18. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism.
Zabłocka-Słowińska K; Płaczkowska S; Skórska K; Prescha A; Pawełczyk K; Porębska I; Kosacka M; Grajeta H
PLoS One; 2019; 14(4):e0215246. PubMed ID: 30973911
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.
Li J; Ma C; Yuan X; Wang X; Li N; Yu R; Liao H
Curr Oncol; 2022 Aug; 29(9):6125-6136. PubMed ID: 36135050
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]